Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03505424 · ClinicalTrials.gov registry record · NA

Supporting All Families of Premature Infants At Prentice Women's Hospital from Admission Through Discharge

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT03505424 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 400 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03505424, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

The objective of this study is to determine the extent to which the SMART NICU2HOME (including EMR interface) and the NICU2HOME apps, mobile applications designed for parents of premature infants to receive daily, real-time information about their infants and personalized education material based on parents' anticipated concerns and their infant's clinical status, is effective in: 1) improving parents' competency in caring for their sick infants, 2) reducing stress, 3) supporting parents' social supports and 3) improving NICU outcomes (parent satisfaction, length of stay, readmission rates.)

Interventions

  • OTHER Group 1: Standard of Care
  • OTHER Group 2: NICU2HOME app
  • OTHER Group 3: SMART NICU2HOME app

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2018-04-20
Est. Completion 2024-04-30
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT03505424

The ClinicalTrials.gov registry entry for NCT03505424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Group 1: Standard of Care is the first listed.

NCT03505424 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03505424 about?

NCT03505424 is a clinical study titled "Supporting All Families of Premature Infants At Prentice Women's Hospital from Admission Through Discharge". The objective of this study is to determine the extent to which the SMART NICU2HOME (including EMR interface) and the NICU2HOME apps, mobile applications designed for parents of premature infants to receive daily, real-time information about their infants and personalized education material based on...

What is the current status of trial NCT03505424?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2018-04-20. Estimated completion is 2024-04-30.

What interventions are being tested in trial NCT03505424?

The interventions under investigation include: Group 1: Standard of Care (OTHER), Group 2: NICU2HOME app (OTHER), Group 3: SMART NICU2HOME app (OTHER).

Who is sponsoring clinical trial NCT03505424?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.